Aimmune Submits Marketing Authorization Application to European Medicines Agency for AR101 for Peanut Allergy

81

BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Submits Marketing Authorization Application to European Medicines Agency for AR101 for Peanut Allergy…..

 

 

 

http://www.businesswire.com/news/home/20190628005065/en/Aimmune-Submits-Marketing-Authorization-Application-European-Medicines

 

- Advertisement -